
Join to view full profile
1700 Matthews Township PkwyMatthews, NC 28105
Phone+1 980-302-7010
Fax+1 704-841-9228
Dr. Newman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Alfred Newman III, MD is an Oncologist based in Matthews, NC with expertise in head and neck oncology and thoracic oncology. He completed his fellowship and residency at the University of Alabama Medical Center, specialized in Hematology and Medical Oncology, and Internal Medicine respectively. He is also a graduate from the University of Alabama School of Medicine. Dr. Newman is a published researcher; his work on Fibroblast Growth Factor Receptor Inhibitor in squamous cell lung cancer has been cited by other publications 55 times. He is a recipient of the CMS Meaningful Use Stage 1 Certification from OncoEMR, Altos Solutions, Inc. in 2012-2013.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Hematology and Medical Oncology, 2002 - 2004
University of Alabama Hospital (Birmingham)Residency, Internal Medicine, 1999 - 2002
University of Alabama School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2004 - 2027
AL State Medical License 2000 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 76 citationsSWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pat...Charu Aggarwal, Mary W. Redman, Primo N. Lara, Hossein Borghaei, Philip C. Hoffman
Journal of Thoracic Oncology. 2019-10-01 - 6 citationsWhat about the trach? Tracheotomy removal as a palliative care maneuver.Alfred J. Newman, Elizabeth Kvale, Beverly R. Williams, F. Amos Bailey
The American Journal of Hospice & Palliative Care. 2007-10-01
Authored Content
- A phase I study of capecitabine and concurrent radiotherapy (RT) for patients with newly diagnosed glioblastoma multiforme (GBM)July 2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: